Alexion Pharmaceuticals
Rachel McDonnell is an experienced professional in the pharmaceutical and medical sectors, currently serving as the Head of Strategic Business Planning & Execution for US Medical Affairs at Alexion Pharmaceuticals, Inc. since May 2022. Prior to this role, Rachel held several key positions at Biogen from 2016 to 2022, including Interim Head of Global Medical Business Operations and Head of Global Grants Management & Strategic Giving. Rachel also contributed to educational development as Vice President at DBC Pri-Med from 2011 to 2016. Earlier in career, positions included various roles at M|C Communications, LLC, Key3Media, and GE Capital, focusing on financial analysis and operational development. Rachel holds a Bachelor of Science in Finance from Bentley University.
This person is not in any teams
This person is not in any offices